HDFC Pharma and Healthcare Fund Direct Plan Growth vs Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment
NAV, returns and costs — not a recommendation.
 HDFC Pharma and Healthcare Fund Direct Plan Growth |  Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment | |
|---|---|---|
| NAV | ₹21.944 | ₹26.32 |
| NAV date | 2026-09-30 | 2026-09-29 |
| 1 year | +27.80% | +11.92% |
| 3 year (p.a.) | +30.22% | +15.14% |
| 5 year (p.a.) | +30.22% | +8.05% |
| Expense ratio | 0.92% | 0.84% |
| Fund size | ₹3,310.64 Cr | ₹950.31 Cr |
| Risk | Very high | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.